Frontlight ResearchEarly access
Trial site
Novosibirsk
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Multiple sclerosis2 trials
- Stroke2 trials
- Phase
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals5 trials
Running trials
Active, not recruiting
Recruiting
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026